Senseonics Holdings, Inc. (SENS)

Last Price:  

Company Description

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $21.30M
Net Income (Most Recent Fiscal Year) $-115.55M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 4.86
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -717.14%
Net Margin (Trailing 12 Months) -720.59%
Return on Equity (Trailing 12 Months) -673.12%
Return on Assets (Trailing 12 Months) -129.93%
Current Ratio (Most Recent Fiscal Quarter) 1.71
Quick Ratio (Most Recent Fiscal Quarter) 1.43
Debt to Common Equity (Most Recent Fiscal Quarter) --
Inventory Turnover (Trailing 12 Months) 3.67
Book Value per Share (Most Recent Fiscal Quarter) $-0.04
Earnings per Share (Most Recent Fiscal Quarter) $-0.21
Earnings per Share (Most Recent Fiscal Year) $-0.67
Diluted Earnings per Share (Trailing 12 Months) $-0.66
Exchange NYSEMKT
Sector Healthcare
Industry Diagnostics & Research
Common Shares Outstanding 227.64M
Free Float 205.33M
Market Capitalization $87.30M
Average Volume (Last 20 Days) 4.02M
Beta (Past 60 Months) 0.46
Percentage Held By Insiders (Latest Annual Proxy Report) 9.80%
Percentage Held By Institutions (Latest 13F Reports) 40.54%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%